Viz.ai One vs. OpenEvidence
A side-by-side comparison based on G2 review data.
| Metric | Viz.ai One | OpenEvidence |
|---|---|---|
| Overall rating | 4.3 | 4.4 |
| Review count | 29 | 37 |
| Ease of use | 8.6 | 9.3 |
| Ease of setup | 8.9 | 9.1 |
| Quality of support | 9.1 | 8.9 |
| Meets requirements | 9.0 | 8.9 |
| NPS | 56 | 64.864865 |
| Small Business | 31.0% | 51.4% |
| Mid-Market | 44.8% | 29.7% |
| Enterprise | 24.1% | 18.9% |
| Total page views | 90 | 621 |
| Total LLM citations | 4 | 5,516 |
Viz.ai One
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes.
OpenEvidence
OpenEvidence is a medical information platform designed to assist healthcare professionals in navigating the vast and rapidly expanding body of medical research. Originating from the Mayo Clinic Platform Accelerate program, it integrates multimedia and clinical findings from esteemed sources like The New England Journal of Medicine. By aggregating, synthesizing, and presenting clinically relevant evidence in accessible formats, OpenEvidence empowers medical practitioners to make informed, evidence-based decisions, ultimately enhancing patient outcomes.